leisure time -WSS

leisure time

author：knowledge 2025-10-03 00:38:11 - browse：3

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Better Therapeutics data on benefit with GLP

hotspot

WSS

There’s no way to know how good AI health technologies are

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Being 'nonadherent' patient made me a more empathetic doctor

The biotech scorecard for Q3: 15 stock

UpToDate has a racism problem: Dr. Stanley Goldfarb

Humana CEO Bruce Broussard to step down in 2024

hotspot

leisure time

hotspot

Walensky prepares to leave CDC — and Congress — behind

Skip the lead apron during X

Cancer drug shortages should be causing more outrage

Dexcom's push to bring CGM to type 2 diabetes patients

Dobbs anniversary: the lost opportunity of abortion as health care

Crowdfunding for unproven stem cell procedures spreads misinformation

After affirmative action ruling, medical educators look to 'holistic review'

Takeaways from AdvaMed, the largest medical devices conference

Alkermes shareholders re

European regulators recommend Amylyx's ALS drug be rejected

leisure time

The biotech scorecard for Q3: 15 stock

There’s no way to know how good AI health technologies are

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Nick Jonas talks about managing diabetes along with his career

STAT Readout: Today's biotech news includes Sana and Amylyx

hotspot

knowledge

explore

explore